652 related articles for article (PubMed ID: 7948129)
41. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
42. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
Robbins PB; Yu XJ; Skelton DM; Pepper KA; Wasserman RM; Zhu L; Kohn DB
J Virol; 1997 Dec; 71(12):9466-74. PubMed ID: 9371608
[TBL] [Abstract][Full Text] [Related]
43. Evidence that the mouse 3' kappa light chain enhancer confers position-independent transgene expression in T- and B-lineage cells.
Xu L; Tsuji K; Mostowski H; Candotti F; Rosenberg A
Hum Gene Ther; 2003 Dec; 14(18):1753-64. PubMed ID: 14670126
[TBL] [Abstract][Full Text] [Related]
44. Establishment of modified retroviral vector targeting X-linked severe combined immunodeficiency.
Zhi CL; Migita M; Hayakawa J; Fukunaga Y
J Nippon Med Sch; 2004 Feb; 71(1):51-6. PubMed ID: 15129596
[TBL] [Abstract][Full Text] [Related]
45. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
[TBL] [Abstract][Full Text] [Related]
46. Retrovirus-mediated gene transfer and expression of human ornithine delta-aminotransferase into embryonic fibroblasts.
Rivero JL; Lacorazza HD; Kozhich A; Nussenblatt RB; Jendoubi M
Hum Gene Ther; 1994 Jun; 5(6):701-7. PubMed ID: 7948132
[TBL] [Abstract][Full Text] [Related]
47. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
48. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
[TBL] [Abstract][Full Text] [Related]
49. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
50. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
51. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.
Engels B; Noessner E; Frankenberger B; Blankenstein T; Schendel DJ; Uckert W
Hum Gene Ther; 2005 Jul; 16(7):799-810. PubMed ID: 16000062
[TBL] [Abstract][Full Text] [Related]
52. Factors affecting retroviral vector function and structural integrity.
McLachlin JR; Mittereder N; Daucher MB; Kadan M; Eglitis MA
Virology; 1993 Jul; 195(1):1-5. PubMed ID: 8391178
[TBL] [Abstract][Full Text] [Related]
53. The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts.
Volkova NA; Fomina EG; Smolnikova VV; Zinovieva NA; Fomin IK
J Biol Chem; 2014 Jul; 289(29):20158-69. PubMed ID: 24878957
[TBL] [Abstract][Full Text] [Related]
54. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
[TBL] [Abstract][Full Text] [Related]
55. Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene.
Metz MZ; Matsumoto L; Winters KA; Doroshow JH; Kane SE
Virology; 1996 Mar; 217(1):230-41. PubMed ID: 8599208
[TBL] [Abstract][Full Text] [Related]
56. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
Konetschny C; Holzer GW; Falkner FG
J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
[TBL] [Abstract][Full Text] [Related]
57. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
[TBL] [Abstract][Full Text] [Related]
58. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
59. Negative regulation of the 5' long terminal repeat (LTR) by the 3' LTR in the murine proviral genome.
Gama Sosa MA; Rosas DH; DeGasperi R; Morita E; Hutchison MR; Ruprecht RM
J Virol; 1994 Apr; 68(4):2662-70. PubMed ID: 8139043
[TBL] [Abstract][Full Text] [Related]
60. Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector.
Rasmussen JA; Gilboa E
J Virol; 1987 May; 61(5):1368-74. PubMed ID: 3573142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
